Failed to load this image.

1:1 CBD:THC

4.6 out of 5 stars
4.6

(18 reviews)
ROVE

Remedies Cartridge

Description

Cannabidiol or more commonly referred to as CBD is one of 113 cannabinoids found in cannabis plants. CBD, which has been touted for its potential health benefits, has shown promise in reducing pain and inflamation, as well as combating anxiety and seizures. Unlike THC, CBD by itself is 100% non-psychoactive. However, when coupled with lower levels of THC, its effects can be enhanced, providing instantaneous relief. Extracted from high CBD flower using only carbon dioxide, these blends have an 85% total cannabinoid potency and are available in 10:1, 2:1, and 1:1, CBD to THC ratios.

Business Licenses

Share

Opens in new window
Opens in new window
Opens in new window

Check availability for 1:1 CBD:THC

Use your location

Customer Reviews

Filter by rating

4.6 out of 5 stars
4.6

18 reviews

83%

6%

0%

6%

6%

Top activities mentioned

Filter by top activities

Top feelings mentioned

Filter by top feelings

18 reviews

b****w

5.0 out of 5 stars
5.0

One of the best flavors and most well-rounded medicinal relief great for any time of day

Ease my mind

Get relief

Stimulate my mind

Relaxed

Blissful

Pain free

Verified purchase, February 9, 2024

h****r

5.0 out of 5 stars
5.0

Great strain for work

Ease my mind

Get relief

Relaxed

Creative

Verified purchase, April 1, 2022

c****0

2.0 out of 5 stars
2.0

Says a hint of flavor. But the flavor is so overpowering and leaves traces on your mouth. Not enjoyable, no major effects on me either but it's the wierd and strong artificial taste that will be leading me away from another rove purchase.

Verified purchase, October 12, 2020

z****3

4.0 out of 5 stars
4.0

Thanks

Verified purchase, April 15, 2020

l****e

1.0 out of 5 stars
1.0

I paid $30 to feel literally nothing. This is the priciest place I’ve ever been to. They have a specials page that has been under construction for like a year. Because there aren’t any specials.

Verified purchase, December 18, 2019